Understanding Diabetic Retinopathy in Ayurvedic Parlance - A Review Article
Keywords:
Diabetic Retinopathy, Ayurveda, Prameha, Timira, Literary ReviewAbstract
According to WHO 60% of factors related to individual health and quality of life are mutually related to lifestyle. Over 61% of all deaths in India are due to lifestyle or Non Communicable Diseases. Diabetes and diabetic retinopathy have been emerging as an important non communicable disease affecting eye. Prameha leading to dristigata roga based on the basic principles of Ayurveda and effect on netrapatalas leading progressively to timira, kacha, linganasha thereupon is analysed. Charaka Samhita, Sushrutha Samhitha, Ashtanga Hridaya and various research articles and contemporary science books of the concerned subject are referred. Management of the condition involves Nidana Parivarjana and the treatments as per Ayurvedic classics help in Samprapti Vighatana thereby giving relief to the patient. Proper and timely treatment by Ayurveda helps in reversing damage to the eyes and better management of the condition.
References
Healthy Living : What Is a Healthy Lifestyle? World Health Organization. World Health Organization, January 1, 1999. https://apps.who.int/iris/handle/ 10665/108180?show=full.
Lifestyle Disorder. Lifestyle Disorder | National Health Portal of India. Accessed May 1, 2020. https://www. nhp.gov.in/lifestyle-disorder_mtl.
Sharma NC. Government Survey Found 11.8% Prevalence of Diabetes in India. Livemint, October 10, 2019. https://www.livemint.com/science/health/ government-survey-found-11-8-prevalence-ofdiabetes-in-india-11570702665713.html.
Steele, Chris. Diabetes and the Eye. 2008th ed. Edinburgh: Elsevier Limited, n.d.
Acharya S. Sushrutha Samhitha with Nibandha Sangraha Commentary of Dalhanacharya. 2014th ed. Vol. Shareerasthana. Varanasi: Chaukhamba Krishnadas academy, 2014.
Acharya, Agnivesha. Charaka Samhitha . 2008th ed. Vol. Suthrasthana. Chaukhamba Surabharathi prakashan, n.d.
Srinivasa R. Samhitha B. 1st ed. Vol. Shareerasthana. Chaukhamba Krishnadas academy, 2010.
Acharya, Vagbhata. Ashtanga Hrudaya with Commentaries of Arunadatta and Hemadri, Suthrasthana. 2002nd ed. Chaukhamba surabharathi prakashana, n.d.
Agnivesha A. Charaka Samhitha Chikitsasthana. 2008th ed. Chaukhamba Surabharathi prakashan, n.d.
Acharya, Sushrutha. Sushrutha Samhitha with Nibandha Sangraha Commentary of Dalhanacharya. 2014th ed. Vol. Suthrasthana. Varanasi: Chaukhamba Krishnadas academy, 2014.
Acharya, Agnivesha. CharakaSamhitha. 2008th ed. Vol. Suthrasthana. Chaukhamba Surabharathi prakashan, n.d.
Acharya, Agnivesha. CharakaSamhitha. 2008th ed. Vol.Chikitsasthana. Chaukhamba Surabharathi prakashan,n.d.
Acharya, Vagbhata. Ashtanga Hrudaya with Commentaries of Arunadatta and Hemadri, Suthrasthana. 2002nd ed. Chaukhamba surabharathi prakashana, n.d.
Acharya, Agnivesha. CharakaSamhitha. 2008th ed. Vol. Nidanasthana. Chaukhamba Surabharathi prakashan, n.d.
Acharya,Vagbhata. Ashtanga Hrudaya with Commentaries of Arunadatta and Hemadri, Suthrasthana. 2002nd ed. Chaukhamba surabharathi prakashana, n.d.
Chandrakant, Vd. Khendkar Jayashree and Pawar Jatved Janardhanrao. Physiological and Clinical Significance of Srotas. International Journal of Health Sciences and Research 6, no. 9 (September 2016).
Acharya, Sushrutha. Sushrutha Samhitha with Nibandha Sangraha Commentary of Dalhanacharya. 2014th ed. Vol.Uttarasthana. Varanasi: Chaukhamba Krishnadas academy, 2014.
Acharya, Sushrutha. Sushrutha Samhitha with Nibandha Sangraha Commentary of Dalhanacharya. 2014th ed. Vol.Uttarasthana. Varanasi:Chaukhamba Krishnadas academy, 2014.
Acharya, Agnivesha. Charaka Samhitha Chikitsasthana. 2008th ed. Chaukhamba Surabharathi prakashan, n.d.
Gowda, Shivkumar. Ayurvedeeya Shareera Kriya Vijnana. 5th ed. Rohtak: Nath Pusthaka bhandara, n.d.
Sahoo, Prashanth Kumar, and Shamsa Fiaz. Conceptual Analysis of Diabetic Retinopathy in Ayurveda. Journal of Ayurveda and Integrative Medicine 2017.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
